BRIDGEWAY CAPITAL MANAGEMENT, LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q1 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q1 2023$72,758
+10.4%
205,3000.0%0.00%0.0%
Q4 2022$65,881
-56.1%
205,3000.0%0.00%
-50.0%
Q3 2022$150,000
-18.9%
205,3000.0%0.00%0.0%
Q2 2022$185,000
-39.5%
205,3000.0%0.00%
-33.3%
Q1 2022$306,000
-49.3%
205,300
+95.0%
0.01%
-45.5%
Q2 2021$604,000
-41.9%
105,300
-47.4%
0.01%
-42.1%
Q1 2021$1,040,000
+70.5%
200,300
-21.5%
0.02%
+46.2%
Q4 2020$610,000
+71.8%
255,3000.0%0.01%
+62.5%
Q3 2020$355,000
+19.5%
255,300
+64.4%
0.01%
+33.3%
Q2 2020$297,000
-47.3%
155,300
-32.6%
0.01%
-53.8%
Q1 2020$564,000
+8.9%
230,3000.0%0.01%
+85.7%
Q4 2019$518,000
-8.8%
230,300
-14.8%
0.01%
-12.5%
Q3 2019$568,000
+34.0%
270,300
+58.7%
0.01%
+60.0%
Q2 2019$424,000
-44.9%
170,300
-12.7%
0.01%
-50.0%
Q1 2019$770,000
+186.2%
195,0000.0%0.01%
+150.0%
Q4 2018$269,000
-64.1%
195,000
-35.0%
0.00%
-42.9%
Q3 2018$750,000
-2.0%
300,0000.0%0.01%
-12.5%
Q2 2018$765,000
+216.1%
300,000
+160.9%
0.01%
+166.7%
Q1 2018$242,000
-64.1%
115,000
-20.7%
0.00%
-57.1%
Q4 2017$674,000
-38.4%
145,0000.0%0.01%
-41.7%
Q3 2017$1,095,000
+45.2%
145,0000.0%0.01%
+33.3%
Q2 2017$754,000
-12.9%
145,0000.0%0.01%
-10.0%
Q1 2017$866,000
+22.8%
145,000
+45.0%
0.01%
+11.1%
Q4 2016$705,000
+39.9%
100,0000.0%0.01%
+12.5%
Q3 2016$504,000
+41.6%
100,0000.0%0.01%
+33.3%
Q2 2016$356,000100,0000.01%
Other shareholders
ONCOCYTE CORP shareholders Q1 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders